Public Health Abortion Grant Program - Establishment
SB848 establishes the Public Health Abortion Grant Program in Maryland and creates a dedicated Public Health Abortion Grant Program Fund to support it. The program is intended to improve access to abortion care clinical services for individuals in the State, especially people without sufficient resources, including those who are uninsured, underinsured, or unable to use insurance because of communications risks from carriers. The Department of Health is directed to award operating grants to eligible organizations that provide equitable access to abortion care or administer funds for that purpose, and at least 90% of appropriated program funds must go out as grants.
The bill also directs how certain abortion-related premium funds collected by insurers and health maintenance organizations must be used. Those funds must first support abortion coverage for insureds or enrollees, and excess balances in segregated accounts are to be transferred to the new grant program fund under specified timelines. The law requires annual accounting to the Insurance Commissioner, sets confidentiality protections for grant applicants, recipients, providers, and patients, and limits disclosure of identifying information. It also includes a federal contingency clause: if CMS determines the insurance provisions violate federal ACA Section 1303, those provisions are automatically abrogated.
In state law, SB848 adds new provisions to the Insurance Article, the Health – General Article, and the State Finance and Procurement Article. It creates a special, nonlapsing fund outside the usual interest-allocation rules and exempts the new fund from the general requirement that interest on special funds accrue to the General Fund. The Governor is required to allocate $2 million to the program by budget amendment for fiscal year 2026, and beginning in fiscal year 2027 must include an annual appropriation at least equal to the amount required to be transferred under the insurance provisions.
The overall sentiment reflected in the vote history is that the bill ultimately had strong support, though it faced some opposition and attempted amendments. Several floor amendments were rejected in the Senate, and the bill then passed both chambers by comfortable margins. The absence of committee transcript material limits insight into detailed debate, but the voting pattern suggests the measure was broadly supported while still drawing meaningful dissent.
The main point of contention is the use of abortion-related insurance premium funds and state resources to finance abortion access for people without sufficient resources. Opponents appear to have sought amendments, likely to narrow or alter the bill’s scope, but those efforts failed. Supporters, by contrast, appear to have favored creating a stable funding stream and confidentiality protections to expand access to abortion care and reduce barriers for patients and providers.
SB848 amends Maryland insurance, health, and budget law to create a new grant program and dedicated fund for abortion access. It changes how certain abortion-related premium funds are handled, requires transfers of excess segregated account balances into the new fund, exempts the fund from general interest-allocation rules, and mandates state budget support beginning in fiscal year 2027. It also imposes reporting, confidentiality, and administrative requirements on the Maryland Insurance Administration and the Department of Health, affecting insurers, HMOs, eligible provider organizations, and individuals seeking abortion care.
The bill appears to have been generally favored by a legislative majority, as shown by its passage in both chambers after several rejected amendments. The vote history suggests support for expanding abortion access and creating a dedicated funding mechanism, while also indicating that a substantial minority opposed the measure or sought to modify it. With no committee transcript available, the record mainly shows a successful but contested bill rather than a unanimously embraced one.
The central controversy is abortion policy itself, particularly whether insurance-collected premium funds and state appropriations should be used to subsidize abortion care and related administrative costs. Opponents likely objected to the bill’s funding structure, its use of segregated account balances, and the creation of a special fund for abortion services, as reflected by multiple failed floor amendments. Supporters emphasized access, confidentiality, and funding stability for people without sufficient resources, while the bill also tries to address legal risk through a federal severability/abrogation clause tied to ACA Section 1303.